Agonist Effects of Propranolol on Non-Tumor Human Breast Cells

The β-blocker propranolol (PROP) has been proposed as a repurposed treatment for breast cancer. The similarity of action between β-agonists and antagonists found on breast cells encouraged us to compare PROP and isoproterenol (ISO, agonist) signaling pathways on a human breast cell line. Cell prolif...

Descripción completa

Detalles Bibliográficos
Autores principales: Gargiulo, Lucía, Rivero, Ezequiel Mariano, di Siervi, Nicolás, Buzzi, Edgardo David, Buffone, Mariano Gabriel, Davio, Carlos Alberto, Lüthy, Isabel Alicia, Bruzzone, Ariana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226086/
https://www.ncbi.nlm.nih.gov/pubmed/32331276
http://dx.doi.org/10.3390/cells9041036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226086/
https://www.ncbi.nlm.nih.gov/pubmed/32331276
http://dx.doi.org/10.3390/cells9041036

Ejemplares similares